Literature DB >> 14718391

Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers.

Ashok Kumar1, Niraj Khandelwal, Rahul Malya, Michael B Reid, Aladin M Boriek.   

Abstract

Dystrophin is a cytoskeletal protein found at the inner surface of skeletal and cardiac muscle fibers. We hypothesize that deficiency of dystrophin increases muscle compliance and causes an aberrant mechanotransduction in muscle fibers. To test this hypothesis, we measured the length-tension relationships and determined intracellular signaling leading to the activation of mitogen-activated protein (MAP) kinases in diaphragm muscle fibers from dystrophin-deficient mdx mice. Compared with controls, length-tension curves of the mdx mice were shifted to the right. A higher level of activation of extracellular signal-regulated kinase 1/2 (ERK1/2) but not c-Jun N-terminal kinase-1 or p38 MAP kinase was observed in the mdx muscle compared with the normal muscle in response to mechanical stretch. Removal of Ca2+ from the medium inhibited stretch-induced ERK1/2 activation only in mdx muscle fibers but not in the normal fibers. Conversely, pretreatment with TMB-8 (an antagonist of intracellular Ca2+ blocked the mechanical stretch-induced ERK1/2 activation in normal but not in mdx muscle fibers. Pretreatment of muscle with nifedipine (L-type calcium channel antagonist) marginally decreased the activation of ERK1/2 in normal or mdx muscle whereas pretreatment with gadolinium (III) chloride (an inhibitor of stretch-activated channels) only blocked the activation of ERK1/2 in mdx muscle, with no significant effect on normal muscle. A higher basal level of activation of activator protein-1 (AP-1) transcription factor was observed in dystrophin-deficient diaphragm, which was further augmented by mechanical stretch. Mechanical stretch-induced activation of AP-1 was decreased by pretreatment of muscle fibers with PD98059 (ERK1/2 inhibitor) and removal of Ca2+ ions from incubation medium. Our results show that dystrophin is a load-bearing element and its deficiency leads to loss of muscle stiffness and aberrant mechanotransduction in skeletal muscle fibers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718391     DOI: 10.1096/fj.03-0453com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  63 in total

1.  Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy.

Authors:  Paul S Sharp; Hema Bye-a-Jee; Dominic J Wells
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

2.  Genome-wide Mechanosensitive MicroRNA (MechanomiR) Screen Uncovers Dysregulation of Their Regulatory Networks in the mdm Mouse Model of Muscular Dystrophy.

Authors:  Junaith S Mohamed; Ameena Hajira; Michael A Lopez; Aladin M Boriek
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

3.  Induction of Sirt1 by mechanical stretch of skeletal muscle through the early response factor EGR1 triggers an antioxidative response.

Authors:  Patricia S Pardo; Junaith S Mohamed; Michael A Lopez; Aladin M Boriek
Journal:  J Biol Chem       Date:  2010-10-22       Impact factor: 5.157

4.  Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.

Authors:  Karim Hnia; Gerald Hugon; François Rivier; Ahmed Masmoudi; Jacques Mercier; Dominique Mornet
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 5.  Mechanical properties of respiratory muscles.

Authors:  Gary C Sieck; Leonardo F Ferreira; Michael B Reid; Carlos B Mantilla
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

Review 6.  Fluorescence-based force/tension sensors: a novel tool to visualize mechanical forces in structural proteins in live cells.

Authors:  Jun Guo; Frederick Sachs; Fanjie Meng
Journal:  Antioxid Redox Signal       Date:  2014-01-15       Impact factor: 8.401

7.  Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.

Authors:  Akhilesh Kumar; Shephali Bhatnagar; Ashok Kumar
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

8.  Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.

Authors:  Saurabh Dahiya; Srikanth Givvimani; Shephali Bhatnagar; Natia Qipshidze; Suresh C Tyagi; Ashok Kumar
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

9.  L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers.

Authors:  Karim Hnia; Jérôme Gayraud; Gérald Hugon; Michèle Ramonatxo; Sabine De La Porte; Stefan Matecki; Dominique Mornet
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

10.  Enhanced Na+/H+ exchange activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 receptors.

Authors:  Yuko Iwata; Yuki Katanosaka; Takashi Hisamitsu; Shigeo Wakabayashi
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.